Accelerating Innovations into CarE (AICE): who it is for and how to apply

Accelerating Innovations into CarE (AICE) is non-dilutive funding for Alberta-based health technology SMEs that need preclinical or clinical evidence to reach the market. It covers up to 75% of total eligible project costs, with up to $300,000 for the Validate stream. The intake form for the next round is due November 27, 2026, ahead of the full application date of January 15, 2027.

Key facts

ItemWhat the official page says
Funding shareUp to 75% of total eligible project costs, depending on the stream
Validate stream limitUp to $300,000
Your contributionAt least 25 per cent of total eligible project costs, in cash or in kind
Project termUp to 24 months
RepayableNon-dilutive funding; read the investment agreement template on the program page for the terms
Intake form deadlineNovember 27, 2026
Full application dateJanuary 15, 2027

Who it is for, and who it is not for

The program is open to for-profit small and medium-sized enterprises with a real Alberta footprint: significant physical and corporate operations in the province, appropriate Alberta ownership, and a clear intent that the benefits flow mainly within Alberta. The project has to be an innovative technology that could directly improve health outcomes and needs significant preclinical, safety or clinical efficacy evidence to win regulatory approval, reimbursement or market adoption.

  • A good fit: medical devices, diagnostics and regulated digital health products that need validation evidence before they can be sold or reimbursed.
  • Generally not a good fit: clinic or hospital back-end and practice management software, natural health products, and unregulated products such as health information apps, virtual communication platforms, direct to consumer goods and wellness products.
  • Not for companies without an Alberta base, and not for research that has no path to a product.

What it pays for

The program runs staged streams matched to how ready your technology and business are. The Validate stream pays for technology refinement and early validation of safety, efficacy and value proposition. The Market Access stream pays for later-stage efficacy validation and post-market studies to win market access and adoption in different jurisdictions. Your stage is assessed against the funder's Health Innovation Roadmap, which scores readiness across technology, product-market fit, business and regulatory domains.

The funder publishes its own list of eligible and ineligible costs and a sample application form with the program guide. Read both before you build the budget: costs outside that list come out of your share, and the funder works with you during intake to confirm which stream fits.

A worked example

Hypothetical example

An Alberta medical device company plans a Validate project with total eligible costs of $400,000.

At the maximum share, the program could cover $300,000, capped at the Validate stream limit.

The company then funds the remaining $100,000 itself, in cash or in kind. The program asks every applicant for at least 25 per cent of total eligible project costs.

The deadline and how the intake works

  • Self-assess your fit against the program guide and the roadmap.
  • Submit the intake form through the funder's SmartSimple portal by November 27, 2026. The funder asks for it as early as possible.
  • Wait for feedback on readiness and basic eligibility, with the option of an intake meeting to confirm fit.
  • Submit the full application through the portal by January 15, 2027. Full applications are reviewed in cohorts through the year.
  • Applications are reviewed by the funder's staff and external experts on the technology, the business opportunity, the risk profile and the potential return to Alberta.

Missing the intake form deadline means waiting for the next full application date, even if your full application is ready. Start with the intake form now.

What a strong application needs

Reviewers weigh the technology and the business together, so a strong application shows both. Place your product honestly on the Health Innovation Roadmap and show you have finished the work the stream expects before you apply; claiming a later stage than your evidence supports is a quick way to lose credibility with the reviewer. Tie every milestone to evidence a regulator, payer or buyer will accept, such as a study protocol, a regulatory pathway or a clinical partner.

  • A clear regulatory pathway and who will run the studies.
  • A budget built from the funder's eligible cost list, with your own contribution shown as cash or in kind.
  • Evidence of the market: who pays for the product, and how it gets adopted in Alberta and beyond.
  • Milestones that match the program's own measures: regulatory approvals, private investment, revenue and jobs in Alberta.

Questions

Who can apply to Accelerating Innovations into CarE (AICE)?

Alberta-based for-profit SMEs with significant operations and appropriate ownership in Alberta, whose health technology needs preclinical, safety or clinical evidence to reach the market. Unregulated wellness products, back-end clinic software and natural health products are generally not a fit.

How much funding does Accelerating Innovations into CarE (AICE) provide?

Up to 75% of total eligible project costs depending on the stream, with up to $300,000 for the Validate stream. The applicant covers at least 25 per cent of total eligible project costs in cash or in kind.

When is the Accelerating Innovations into CarE (AICE) deadline?

The intake form is due November 27, 2026 for the full application date of January 15, 2027. The intake form has to come first, so a late intake form pushes you to the following round.

How long can a project run?

Up to 24 months. Plan milestones that the evidence you generate can meet inside that term.

Your next step

Run the Grant Check